drugset / Trial / NCT01574651
The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of QVA149 compared to tiotropium plus formoterol in patients with moderate to severe COPD.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | QVA149 | Other / unclassified | 50 ug | Inhaled |
| Subject | QVA149 | Other / unclassified | 110 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | Inhaled |